Steroid Toxicity Diagnosis and Management

Introduction to Steroid Toxicity

The diagnosis of steroid toxicity requires a systematic evaluation of clinical manifestations and laboratory findings based on the affected organ systems, with immediate discontinuation or dose reduction of the steroid as the primary intervention for severe cases, as recommended by the American College of Physicians 1

Steroid toxicity can cause a range of clinical manifestations, including Cushingoid features (moon facies, buffalo hump, central obesity, and striae), hyperglycemia, proximal muscle weakness, osteoporosis, avascular necrosis of joints, hypertension, fluid retention, and electrolyte abnormalities (particularly hypokalemia), requiring regular monitoring of blood glucose levels, bone density testing, and other relevant assessments 1

A comprehensive neurological examination (including MRI/MRA brain or spine and nerve conduction studies) is recommended for patients presenting with neurological symptoms, as outlined by the American Academy of Neurology 1
For hepatic toxicity, liver function tests and ultrasound are recommended if abnormal, while for cardiac toxicity, ECG and echocardiogram are recommended if symptoms are present, as suggested by the American Heart Association 1
Renal toxicity requires urinalysis, BUN/creatinine, and GFR calculation, emphasizing the importance of regular monitoring of renal function 1

The severity of steroid toxicity can be graded as mild, moderate, or severe, with management strategies including dose reduction, withholding of steroid, initiation of prednisolone, and hospitalization with organ-specific management, as recommended by the American College of Physicians 1
The management of steroid toxicity involves a systematic approach, including assessment of exposure history, evaluation of high-risk factors, and system-specific assessment, to minimize long-term complications 1

Patients with certain conditions (pregnancy, children, elderly, immunocompromised status, diabetes mellitus) require additional monitoring and precautions, including regular growth monitoring, prophylactic measures, and careful dose management, as recommended by the Infectious Diseases Society of America, the Journal of Clinical Oncology, and the Journal of Allergy and Clinical Immunology 2, 3, 1
The use of prophylactic agents to prevent opportunistic infections, careful monitoring, and implementation of preventive measures for known complications are essential in minimizing side effects in patients on long-term corticosteroid therapy, as recommended by the Journal of Clinical Oncology 2
Regular eye examinations to screen for cataracts and glaucoma are necessary, especially in patients receiving higher lifetime cumulative doses of corticosteroids, as reported by the Journal of Allergy and Clinical Immunology 3
Consideration of adjunctive therapies to reduce corticosteroid dose, weighing benefits of therapy against potential growth effects, and monitoring growth regularly are important in managing patients on corticosteroid therapy, as suggested by the Journal of Allergy and Clinical Immunology 3

Using the lowest effective dose for the shortest possible duration, avoiding prolonged use without attempting dose reduction, and considering tapering when appropriate are essential in minimizing side effects, as recommended by the Journal of Clinical Oncology 2